Journal: Scientific Reports
Article Title: P-Rex2 suppresses glucose uptake into liver and skeletal muscle through different adaptor functions
doi: 10.1038/s41598-025-01720-w
Figure Lengend Snippet: P-Rex2 limits glucose uptake into liver cells through Gpr21. ( A ) Glucose uptake. Liver cells from 15-week-old male Prex2 + / + (blue, circles), Prex2 –/– (purple, squares), and Prex2 GD (green, triangles) mice on chow diet were treated with 30 μM GRA2 for 3 h at 37 °C, or mock-treated, followed by the addition of 50 μM 2-DOG, 0.25 μCi 3 H-2-DOG for 60 min. Cells were washed, lysed, and glucose uptake was measured by scintillation counting. Data are mean ± SEM of 9 independent experiments; symbol colours mark individual experiments. Statistics are two-way ANOVA with Sidak’s multiple comparisons correction. P -values in black denote significant differences, p -values in grey are non-significant. ( B ) Glut2 cell surface level. Liver cells were treated with 30 μM GRA2 for 3 h at 37 °C, or mock-treated, stained with Glut2 antibody, analysed by flow cytometry, and the mean fluorescence intensity (mfi) of Glut2 surface level expressed as % of total Glut2. Data are mean ± SEM of 4 independent experiments; symbol colours mark individual experiments. ( C ) Mitochondrial membrane potential. Liver cells were treated with 30 μM GRA2 for 30 min at 37 °C, or mock-treated, stained with MTG and TMRE, and analysed by flow cytometry for TMRE signal in MTG + cells. Data are mean ± SEM of 4 independent experiments; symbol colours mark individual experiments. ( D, E ) Glucose uptake. Liver cells were pretreated with ( D ) 500 nM KL11743 or ( E ) 50 nM wortmannin for 30 min before treatment with 30 μM GRA2 for 3 h at 37 °C, or mock-treatment, followed by the addition of 50 μM 2-DOG, 0.25 μCi 3 H-2-DOG for 60 min. Cells were washed, lysed, and glucose uptake was measured by scintillation counting. Data are mean ± SEM of ( D ) 4 and ( E ) 6 independent experiments; symbol colours mark individual experiments. Statistics ( A – E ) are two-way ANOVA with Sidak’s multiple comparisons correction. P -values in black denote significant differences, p -values in grey are non-significant. ( F ) Model. P-Rex2 limits hepatic glucose clearance by suppressing glucose uptake into liver cells, independently of its Rac-GEF activity, through the constitutively-active, inhibitory GPCR Gpr21. This is likely to occur through the adaptor function of P-Rex2 in regulating the trafficking of active GPCRs, which will limit the internalisation of the Gpr21, thereby enabling Gpr21 to inhibit glucose uptake. Blockade of Gpr21 activity by GRA2 removes the inhibition of glucose uptake. Use of KL11743 and wortmannin under this condition revealed P-Rex2 as a mediator of class I glucose transporter activity and PI3K activity during glucose uptake, both through adaptor functions. In Prex2 –/– liver cells, glucose uptake is increased because Gpr21 is internalised as the block of receptor endocytosis is removed, and Gpr21 can no longer inhibit glucose uptake.
Article Snippet: Once the Prex2 GD strain was fully established, genotyping was done by Transnetyx (Cordova, TN, United States).
Techniques: Staining, Flow Cytometry, Fluorescence, Membrane, Activity Assay, Inhibition, Blocking Assay